BACKGROUND: Elevated serum iron levels have been associated with infectious outcomes in various patient populations but, to our knowledge, have never been studied after liver transplantation. METHODS: The relationship between serum iron levels and infectious outcomes after liver transplantation was evaluated in a nested case-control study using prospectively collected data and serum samples. Unadjusted and adjusted hazard ratios were calculated for each iron marker predictor variable (iron level, unsaturated iron-binding capacity, total iron-binding capacity, transferrin saturation, and ferritin level) and time to development of each of 6 outcomes (cytomegalovirus [CMV] disease, invasive fungal infection, bacteremia, invasive fungal infection or bacteremia, any infection, and 1-year mortality rate). RESULTS: Serum measurements (n = 109) corresponding to increased levels of serum iron were independently associated with an increased risk of any infection and death. After adjusting for the number of red blood cell transfusions, donor CMV-seropositive status, and fungal colonization, ferritin level was independently associated with the development of any infection (hazard ratio, 1.09; 95% confidence interval, 1.04-1.14). After adjusting for the number of red blood cell transfusions, development of CMV disease, and administration of intravenous steroids for treatment of rejection, ferritin level was also was independently associated with death (hazard ratio, 1.11; 95% confidence interval, 1.04-1.18). Similar results were found for unsaturated iron binding capacity for the same 2 outcomes. CONCLUSIONS: A better understanding of iron metabolism and its relationship to infection could help guide future infection prognosis, prevention, and management efforts in this high-risk population.
BACKGROUND: Elevated serum iron levels have been associated with infectious outcomes in various patient populations but, to our knowledge, have never been studied after liver transplantation. METHODS: The relationship between serum iron levels and infectious outcomes after liver transplantation was evaluated in a nested case-control study using prospectively collected data and serum samples. Unadjusted and adjusted hazard ratios were calculated for each iron marker predictor variable (iron level, unsaturated iron-binding capacity, total iron-binding capacity, transferrin saturation, and ferritin level) and time to development of each of 6 outcomes (cytomegalovirus [CMV] disease, invasive fungal infection, bacteremia, invasive fungal infection or bacteremia, any infection, and 1-year mortality rate). RESULTS: Serum measurements (n = 109) corresponding to increased levels of serum iron were independently associated with an increased risk of any infection and death. After adjusting for the number of red blood cell transfusions, donor CMV-seropositive status, and fungal colonization, ferritin level was independently associated with the development of any infection (hazard ratio, 1.09; 95% confidence interval, 1.04-1.14). After adjusting for the number of red blood cell transfusions, development of CMV disease, and administration of intravenous steroids for treatment of rejection, ferritin level was also was independently associated with death (hazard ratio, 1.11; 95% confidence interval, 1.04-1.18). Similar results were found for unsaturated iron binding capacity for the same 2 outcomes. CONCLUSIONS: A better understanding of iron metabolism and its relationship to infection could help guide future infection prognosis, prevention, and management efforts in this high-risk population.
Authors: Dimitrios P Kontoyiannis; Georgios Chamilos; Russell E Lewis; Sergio Giralt; Jorge Cortes; Issam I Raad; John T Manning; Xin Han Journal: Cancer Date: 2007-09-15 Impact factor: 6.860
Authors: Philippe Armand; Haesook T Kim; Corey S Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Robert J Soiffer; Joseph H Antin Journal: Blood Date: 2007-01-18 Impact factor: 22.113
Authors: Nina Singh; Cheryl Wannstedt; Lois Keyes; Debra Mayher; Lisa Tickerhoof; Mohamed Akoad; Marilyn M Wagener; Roy Frye; Thomas V Cacciarelli Journal: Prog Transplant Date: 2007-12 Impact factor: 1.187
Authors: Lan Lin; Erika V Valore; Elizabeta Nemeth; Julia B Goodnough; Victoria Gabayan; Tomas Ganz Journal: Blood Date: 2007-05-31 Impact factor: 22.113
Authors: Philippe Armand; Marie-Michele Sainvil; Haesook T Kim; Joanna Rhodes; Corey Cutler; Vincent T Ho; John Koreth; Edwin P Alyea; Ellis J Neufeld; Raymond Y Kwong; Robert J Soiffer; Joseph H Antin Journal: Am J Hematol Date: 2012-04-04 Impact factor: 10.047
Authors: Jennifer K L Chow; Tomas Ganz; Robin Ruthazer; Mary Ann Simpson; Elizabeth A Pomfret; Fredric D Gordon; Mark E Westerman; David R Snydman Journal: Liver Transpl Date: 2017-12 Impact factor: 5.799
Authors: Leonard I Boral; Zane G Staubach; Reny de Leeuw; Duncan C Macivor; Richard Kryscio; Henrietta S Bada Journal: Am J Clin Pathol Date: 2013-12 Impact factor: 2.493
Authors: Jacqueline M McBride; Daniel Sheinson; Jenny Jiang; Nicholas Lewin-Koh; Barbara G Werner; Jennifer K L Chow; Xiaoning Wu; Jorge A Tavel; David R Snydman Journal: Open Forum Infect Dis Date: 2019-01-14 Impact factor: 3.835